Search
GWAS ID | Year | Trait | Consortium | Sample size | Number of SNPs |
---|---|---|---|---|---|
finn-b-CD2_INSITU_BREAST_EXALLC | 2021 | Carcinoma in situ of breast (all cancers excluded) | NA | — | 16,379,075 |
finn-b-CD2_INSITU_BREAST_INTRADUCTAL | 2021 | Carcinoma in situ of breast, intraductal | NA | — | 16,379,784 |
finn-b-CD2_INSITU_BREAST_NOS | 2021 | Carcinoma in situ of breast, other/unspecified | NA | — | 16,379,784 |
finn-b-CD2_INSITU_CERVIX_UTERI | 2021 | Carcinoma in situ of cervix uteri | NA | — | 16,379,784 |
finn-b-CD2_INSITU_CERVIX_UTERI_EXALLC | 2021 | Carcinoma in situ of cervix uteri (all cancers excluded) | NA | — | 16,378,985 |
Data overview
The GWAS summary datasets are currently organised into the following 18 batches: